1. Home
  2. ESPR vs CZNC Comparison

ESPR vs CZNC Comparison

Compare ESPR & CZNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • CZNC
  • Stock Information
  • Founded
  • ESPR 2008
  • CZNC 1864
  • Country
  • ESPR United States
  • CZNC United States
  • Employees
  • ESPR N/A
  • CZNC N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • CZNC Major Banks
  • Sector
  • ESPR Health Care
  • CZNC Finance
  • Exchange
  • ESPR Nasdaq
  • CZNC Nasdaq
  • Market Cap
  • ESPR 305.0M
  • CZNC 330.3M
  • IPO Year
  • ESPR 2013
  • CZNC N/A
  • Fundamental
  • Price
  • ESPR $1.58
  • CZNC $20.44
  • Analyst Decision
  • ESPR Buy
  • CZNC
  • Analyst Count
  • ESPR 7
  • CZNC 0
  • Target Price
  • ESPR $6.36
  • CZNC N/A
  • AVG Volume (30 Days)
  • ESPR 4.2M
  • CZNC 24.4K
  • Earning Date
  • ESPR 03-04-2025
  • CZNC 05-06-2025
  • Dividend Yield
  • ESPR N/A
  • CZNC 5.49%
  • EPS Growth
  • ESPR N/A
  • CZNC 7.45
  • EPS
  • ESPR N/A
  • CZNC 1.69
  • Revenue
  • ESPR $332,314,000.00
  • CZNC $106,129,000.00
  • Revenue This Year
  • ESPR $5.51
  • CZNC $9.38
  • Revenue Next Year
  • ESPR $1.42
  • CZNC $3.77
  • P/E Ratio
  • ESPR N/A
  • CZNC $12.09
  • Revenue Growth
  • ESPR 185.66
  • CZNC 1.43
  • 52 Week Low
  • ESPR $1.47
  • CZNC $16.50
  • 52 Week High
  • ESPR $3.94
  • CZNC $22.68
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 41.48
  • CZNC 48.63
  • Support Level
  • ESPR $1.47
  • CZNC $19.58
  • Resistance Level
  • ESPR $1.61
  • CZNC $20.51
  • Average True Range (ATR)
  • ESPR 0.12
  • CZNC 0.50
  • MACD
  • ESPR 0.00
  • CZNC -0.07
  • Stochastic Oscillator
  • ESPR 28.21
  • CZNC 43.88

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About CZNC Citizens & Northern Corp

Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.

Share on Social Networks: